Brief: Nextcell Pharma: Long-Term Effects With Repeated Protrans Treatment After 6 Years
17/12/2024 11:50
Dec 17 (Reuters) - NextCell Pharma AB NXTCL.ST :
* LONG-TERM EFFECTS WITH REPEATED PROTRANS TREATMENT AFTER 6 YEARS
* RESULTS SHOW THAT TWO OUT OF THREE PATIENTS IN HIGH-DOSE GROUP INCREASED THEIR INSULIN
PRODUCTION BY 23% AND 34% RESPECTIVELY
Source text: ID:nWkr5M5JC7
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln